Horizon Discovery, a life science spin-out of Cambridge University, signs its second collaboration with pharmaceutical firm AstraZeneca.

Chinese-US contract researcher joins $6.85m series B financing round for US biotechnology company Avelas Biosciences.

US-based pharmaceutical multinational Johnson & Johnson is opening a new biotech incubator in Israel, expected to be operational early this year.

Already launching in December with one of the largest series A rounds in history, Juno Therapeutics extends the venture round by a further $25m.

Madison Vaccines, a life sciences firm developing therapies for prostate cancer, closes $8m series A.

Mobile diabetes management system Glooko raises $7m series A-1 funding from new investors including Samsung Venture Investment Corporation, to scale its system and add messaging for therapeutic recommendations.

WellDoc, developer of a prescription app for managing diabetes, has raised $20m financing from investors including Merck Global Health Innovation Fund.

Amgen spin-off Atara Biotherapeutics raises $52m series B funding from investors including Amgen Ventures and Celgene Corporation, to accelerate clinical development of lead programs.

Stanford spin-out DNAnexus closes $15m series C for platform-as-a-service DNA management software.